Antimicrobial Resistance Policy Review and Development Framework

Sobey, A.

Antimicrobial Resistance Policy Review and Development Framework

A regional guide for governments in Asia and the Pacific to review, update and develop policies to address antimicrobial resistance and antimicrobial use in animal production

Year of publication 2018

Place of publication Bangkok, Thailand ;

Pages 72

Author Sobey, A.

Publisher FAO ;

Product type Book (stand-alone)

ISBN 978-92-5-130947-6

Edition 1

Full item page

Synopsis (short abstract) This publication provides reference and general guidance for countries, specifically policy makers and official, to draft and implement policies on antimicrobial resistance (AMR) and antimicrobial use (AMU) for food animal production within a One health Approach. It offers practical guide for countries to systematically identify, assess and strengthen AMR and AMU policies. The framework described in this publication is designed to help countries review their own national policies and provides examples from countries that facilitate effective national response to AMR.

Language English

Related items

Showing items related by metadata.

Book (stand-alone)
Drivers, Dynamics and Epidemiology of Antimicrobial Resistance In animal production 2016

Also available in:

Russian

It is now accepted that increased antimicrobial resistance (AMR) in bacteria affecting humans and animals in recent decades is primarily influenced by an increase in usage of antimicrobials for a variety of purposes, including therapeutic and non-therapeutic uses in animal production. Antimicrobial resistance is an ancient and naturally occurring phenomenon in bacteria. But the use of antimicrobial drugs – in health care, agriculture or industrial settings – exerts a selection pressure which can favour the survival of resistant strains (or genes) over susceptible ones, leading to a relative increase in resistant bacteria within microbial communities.
Meeting

Joint FAO/OIE/WHO Expert Workshop on Non-Human Antimicrobial Usage and Antimicrobial Resistance: Scientific assessment
Geneva, December 1 – 5, 2003
2003

Also available in:

No results found.

Antimicrobial agents are essential drugs for human and animal health and welfare. Antimicrobial resistance is a global public health concern that is impacted by both human and non-human antimicrobial usage. Antimicrobial agents are used in food animals, including from aquaculture, companion animals and horticulture to treat or prevent disease. Antimicrobial agents are sometimes used in food animals to promote growth. The types of antimicrobials used are frequently the same as, or closely rela ted to, antimicrobials used in humans.
The expert workshop concluded that there is clear evidence of adverse human health consequences due to resistant organisms resulting from non-human usage of antimicrobials. These consequences include infections that would not have otherwise occurred, increased frequency of treatment failures (in some cases death) and increased severity of infections, as documented for instance by fluoroquinolone resistant human Salmonella infections. Evidence shows th at the amount and pattern of non-human usage of antimicrobials impact on the occurrence of resistant bacteria in animals and on food commodities and thereby human exposure to these resistant bacteria. The foodborne route is the major transmission pathway for resistant bacteria and resistance genes from food animals to humans, but other routes of transmission exist. There is much less data available on the public health impact of antimicrobial usage in aquaculture, horticulture and companion an imals.
Brochure, flyer, fact-sheet

FAO initiatives on prevention and control of antimicrobial resistance
Addressing antimicrobial usage in Asia’s livestock production industry
2018

Also available in:

No results found.

This brochure describes a FAO-USAID project with outcomes expected to include regular information and early warning from countries in the region against potential, known and emerging threats; reduced risk and vulnerability at household and community level; and, countries and regions affected by the abuse (AMU) and subsequent prevalence of antimicrobial resistance (AMR), prepare for and manage effective responses.